Bitter Almond
OTHER NAME(S): Almendro Amargo, Amande Amère, Amandier Amer, Amandier a Fruits Amers, Amendoa Amarga, Amygdala Amara, Bitter Almond Oil, Bitter Almond Tree, Bittere Amandel, Bittere Mandel, Bittere Mandeln, Bittere-Amandelboom, Bittermandel, Bittermandelbaum, Bittermandeltae, Bittermandeltraed, Huile d'Amande Volatile, Huile d'Amande Amère, Karvasmanteli, Mandorla Amara, Mandorlo Amaro, Mindal' Gor'kii, Semen Armeniacae Amarum, Volatile Almond Oil, Prunus amygdalus var. amara, Amygdalus communis var. amara, Amygdalus dulcis var. amara, Prunus communis var. amara, Prunus dulcis var. amara, Amande Amere, Almendra Amarga, Amande amère
Overview
Bitter almond (Prunus amygdalus var. amara) is a type of almond. It contains a toxic chemical called amygdalin, which is poisonous when consumed.
The amygdalin in bitter almond turns into poisonous hydrocyanic acid (HCN) in the body. This chemical slows down the nervous system and causes serious breathing problems. Sweet almond (Prunus dulcis), which is the type of almond that is commonly eaten, doesn’t contain these toxins.
People apply bitter almond for stretch marks and other conditions, but there is no good scientific evidence to support these uses.
Don’t confuse bitter almond with sweet almond or apricot kernel. These are not the same.
Uses
We currently have no information for Bitter Almond overview.
Side Effects
When taken by mouth: Bitter almond is likely unsafe. It contains a poisonous chemical that can cause serious side effects, such as slowing of the nervous system, breathing problems, and death.
When applied to the skin: There isn't enough reliable information to know if bitter almond is safe or what the side effects might be.
Precautions
When taken by mouth: Bitter almond is likely unsafe. It contains a poisonous chemical that can cause serious side effects, such as slowing of the nervous system, breathing problems, and death.
When applied to the skin: There isn't enough reliable information to know if bitter almond is safe or what the side effects might be.
Pregnancy and breast-feeding: Bitter almond is likely unsafe when taken by mouth while pregnant or breast-feeding. There isn't enough reliable information to know if bitter almond is safe when applied to the skin. Stay on the safe side and avoid any use.
Surgery: Bitter almond can slow down the nervous system. Anesthesia and other drugs used during surgery do this as well. Using bitter almond along with these medications can slow down the central nervous system too much. Stop using bitter almond at least 2 weeks before a scheduled surgery.
Allergies to peanuts and tree nuts: People with peanut allergies are more likely to be allergic to nuts called "tree nuts." Bitter almond is a tree nut. People who are allergic to one tree nut are also more likely to have an allergy to at least one other tree nut. Avoid eating any tree nuts unless you know that you are not allergic to them.
Interactions
Moderate Interaction
Be cautious with this combination
- Sedative medications (CNS depressants) interacts with Bitter AlmondBitter almond might cause sleepiness and slowed breathing. Some medications, called sedatives, can also cause sleepiness and slowed breathing. Taking bitter almond with sedative medications might cause breathing problems and/or too much sleepiness.
Dosing
There isn’t enough reliable information to know what an appropriate dose of bitter almond might be. Bitter almond might also be unsafe. Speak with a healthcare provider before use.
References
- Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.
- McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.
- Laster, W. R., Jr. and Schabel, F. M., Jr. Experimental studies of the antitumor activity of amygdalin MF (NSC- 15780) alone and in combination with beta-glucosidase (NSC-128056). Cancer Chemother Rep 1975;59(5):951-965.
- Wodinsky, I. and Swiniarski, J. K. Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of transplantable rodent tumors. Cancer Chemother Rep 1975;59(5):939-950.
- Hill, G. J., Shine, T. E., Hill, H. Z., and Miller, C. Failure of amygdalin to arrest B16 melanoma and BW5147 AKR leukemia. Cancer Res 1976;36(6):2102-2107.
- Araya, E., Rodriguez, A., Rubio, J., Spada, A., Joglar, J., Llebaria, A., Lagunas, C., Fernandez, A. G., Spisani, S., and Perez, J. J. Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T. Bioorg.Med Chem Lett. 3-1-2005;15(5):1493-1496.
- Lea, M. A. and Koch, M. R. Effects of cyanate, thiocyanate, and amygdalin on metabolite uptake in normal and neoplastic tissues of the rat. J Natl.Cancer Inst. 1979;63(5):1279-1283.
- Ross, W. E. Unconventional cancer therapy. Compr.Ther 1985;11(9):37-43.
- Biaglow, J. E. and Durand, R. E. The enhanced radiation response of an in vitro tumour model by cyanide released from hydrolysed amygdalin. Int J Radiat Biol Relat Stud.Phys Chem Med 1978;33(4):397-401.
- Ovejera, A. A., Houchens, D. P., Barker, A. D., and Venditti, J. M. Inactivity of DL-amygdalin against human breast and colon tumor xenografts in athymic (nude) mice. Cancer Treat.Rep 1978;62(4):576-578.
- Khandekar, J. D. and Edelman, H. Studies of amygdalin (laetrile) toxicity in rodents. JAMA 7-13-1979;242(2):169-171.
- Stock, C. C., Tarnowski, G. S., Schmid, F. A., Hutchison, D. J., and Teller, M. N. Antitumor tests of amygdalin in transplantable animal tumor systems. J Surg Oncol 1978;10(2):81-88.
- Moertel, C. G., Ames, M. M., Kovach, J. S., Moyer, T. P., Rubin, J. R., and Tinker, J. H. A pharmacologic and toxicological study of amygdalin. JAMA 2-13-1981;245(6):591-594.
- Moertel, C. G., Fleming, T. R., Rubin, J., Kvols, L. K., Sarna, G., Koch, R., Currie, V. E., Young, C. W., Jones, S. E., and Davignon, J. P. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N.Engl.J.Med. 1-28-1982;306(4):201-206.
- Syrigos, K. N., Rowlinson-Busza, G., and Epenetos, A. A. In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibody. Int J Cancer 12-9-1998;78(6):712-719.
- Bhatti RA, Ablin RJ, and Guinan PD. Tumour-associated directed immunity in prostatic cancer: effect of amygdalin. IRCS Med Sci 1981;9(1):19.
- Manner HW, DiSanti SJ, Maggio MI, and et al. Amygdalin, vitamin A and enzyme induced regression of murine mammary adenocarcinomas. J Manip Physiol Ther 1978;1(4):246-248.
- Gostomski FE. The effects of amygdalin on the Krebs-2 carcinoma in adult and fetal DUB (ICR) mice. Disseration Abstracts International 1978;39(5):2075-B.
- Navarro MD. The Philippine experience in the early detection and chemotherapy of cancer. Santo Tomas J Med 1970;25(3):125-133.
- Morrone JA. Chemotherapy of inoperable cancer: preliminary report of 10 cases treated with laetrile. J Exper Med Surg 1962;20:299-308.
- Brown WE, Wood CD, and Smith AN. Sodium cyanide as a cancer chemotherapeutic agent: laboratory and clinical studies. Amer J Obstet Gyn 1960;80(5):907-918.
- Navarro MD. Five years experience with laetrile therapy in advanced cancer. Acta Unio Internat Contra Cancrum 1959;15(suppl 1):209-221.
- Anonymous. Report by the cancer commission of the California Medical Association: the treatment of cancer with "laetriles". California Med 1953;78(4):320-326.
- Milazzo, S., Ernst, E., Lejeune, S., and Schmidt, K. Laetrile treatment for cancer. Cochrane.Database.Syst.Rev 2006;(2):CD005476.
- Chen J, Liu L, Li M, Yu X, Zhang R. An improved method for determination of cyanide content in bitter almond oil. J Oleo Sci. 2018;67(3):289-294.
- Randhawa I, Morphew T, Marsteller NL. Correlation of negative skin-prick test results for tree nuts and successful tree nut challenges among children with peanut allergy. Allergy Asthma Proc. 2018;39(6):456-460.
- Polk BI, Dinakarpandian D, Nanda M, Barnes C, Dinakar C. Association of tree nut and coconut sensitizations. Ann Allergy Asthma Immunol. 2016;117(4):412-416.
- Food and Drug Administration. Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA); Public Law 108-282, Title II. Accessed on May 19, 2021. Available at: https://www.fda.gov/food/food-allergensgluten-free-guidance-documents-regulatory-information/food-allergen-labeling-and-consumer-protection-act-2004-falcpa.